Published Date:2022-03-02 Original Link:https://www.onenessbio.com/en/news_detail146_3.htm No 1 Date of announcement 2022/03/01 Time of announcement 18:42:36 Subject The mechanism of action, Phase 3 MRCT results and post-market cases of the DFU new drug, Fespixon have been accepted for an oral presentation at WUWHS 2022 To which item it meets paragraph 12 Date of events 2022/03/02 Statement Date...Read More